Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Read more about Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer
Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke Read more about Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis Read more about BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
Major Depressive Disorder With Mixed Features - Extension Read more about Major Depressive Disorder With Mixed Features - Extension
Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET Read more about Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study Read more about SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder Read more about SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma Read more about A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
The PRIORi-T Trial--Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation Read more about The PRIORi-T Trial--Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation
Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity Read more about Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity